Labs by research area
Ances Bioimaging Laboratory
Beau M. Ances, MD, PhD
Developing advanced neuroimaging biomarkers to study aging and neurodegeneration. By combining MRI, PET, psychometrics, fluid biomarkers and microbiome data, the lab investigates diseases like Alzheimer’s, Down syndrome and neuroCOVID to improve diagnosis and guide therapies.
Aravamuthan Lab
Bhooma Aravamuthan, MD, DPhil
Focused on understanding the mechanisms underlying movement disorders and neurodevelopmental conditions, particularly dystonia in cerebral palsy. The lab integrates clinical observation with translational research to identify biomarkers, improve diagnostic accuracy and develop targeted therapies. Its mission includes fostering collaboration across disciplines, training future scientists and translating discoveries into interventions that enhance patient care.
Balls-Berry Lab
Joyce Balls-Berry, PhD
Focused on advancing health equity by integrating community engagement into research and education. The lab collaborates with diverse populations to address health disparities, improve access to care and promote culturally responsive interventions. Its mission includes fostering partnerships between researchers and communities, developing inclusive research practices and training future leaders in health equity science.
Bateman Lab
Randall Bateman, MD
Focused on understanding the pathophysiology of Alzheimer’s disease and related neurodegenerative disorders through advanced biomarker research and clinical studies. The lab specializes in developing and validating fluid biomarkers, conducting longitudinal studies and applying innovative techniques such as stable isotope labeling kinetics to measure protein dynamics. Its mission is to accelerate early diagnosis, improve therapeutic strategies and contribute to global efforts in Alzheimer’s research through collaboration and education.
Belloy Lab
Michael Belloy, PhD
Investigating the genetics of Alzheimer’s disease using a multi-modal approach that integrates genomics, imaging and clinical data to identify risk variants and inform drug development.
Brier Lab
Matthew R. Brier, MD, PhD
Using advanced neuroimaging to study how multiple sclerosis progresses despite treatment, aiming to uncover mechanisms of neurodegeneration and identify new therapeutic strategies.
Cirrito Lab
John Cirrito, PhD
Focuses on understanding how amyloid-beta is cleared from the brain and how this process influences Alzheimer’s disease progression. The lab uses advanced imaging, molecular biology and in vivo techniques to study synaptic activity, interstitial fluid dynamics and the role of the blood-brain barrier in amyloid clearance. Its research aims to identify therapeutic targets that can enhance clearance mechanisms and reduce neurodegeneration.
Clifford Lab
David Clifford, MD
Focused on understanding and treating neurological complications of HIV and other neuroinfectious diseases. The lab conducts clinical and translational research to improve diagnosis, management and outcomes for patients affected by these conditions. Its work includes investigating biomarkers, neuroimaging and therapeutic strategies while fostering collaboration to advance global health initiatives and education.
Cross Lab
Anne Cross, MD
Investigating the immunological processes underlying multiple sclerosis and related neuroinflammatory disorders. The lab focuses on understanding how immune cells interact with the central nervous system, identifying biomarkers of disease activity and developing strategies to prevent or reverse neurodegeneration. Its research integrates clinical observations with experimental models to advance therapeutic approaches and improve patient outcomes.
Dang Lab
Mai Dang, MD, PhD
Investigates pediatric brain tumors with a focus on improving treatment through research in tumor biology, immunology and neurology.